Gene therapy products present a unique set of challenges for the control of host cell protein impurities.
Thorsten Strahl
Advertisement
Thorsten Strahl is supervisor protein and scientific officer with Charles River.
Articles by Thorsten Strahl
Advertisement
Latest Updated Articles
Detecting Residual HCPs Demands a Holistic ApproachPublished: July 15th 2021 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Trends in Formulation eBook October 2025
2
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
3
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
4
Analytics, Automation, and Quality Driving the Next Era of Drug Development
5
